RxDoctor Payments Data

Sinju Jacob

Gerontology · Galveston, TXNPI 1346728185

Payments from drug & device makers

$672in general payments, 2019–2025

Across 28 payments — averaging $24.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$163
  • Impulse Dynamics (USA) Inc.$100
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$94
  • Amgen$93
  • Novartis$62
  • Pfizer$42
  • plus $119 from 5 others

What the payments were for

  • Food & beverage$672100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$672 in reported general payments places this provider in the 60th percentile of 653 gerontology providers in Texas.

See all gerontology providers in Texas

Medicare billing

Part B allowed, 2024
$31,830
Medicare patients
260
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$133,694
XareltoRivaroxaban21$25,275
BrilintaTicagrelor28$16,654
Repatha SureclickEvolocumab13$12,439
EntrestoSacubitril/Valsartan16$12,356
Repatha SyringeEvolocumab20$11,800
Atorvastatin Calcium250$2,707
Losartan Potassium173$1,837
Metoprolol Tartrate89$1,635
Metoprolol Succinate119$1,617
Isosorbide Mononitrate ErIsosorbide Mononitrate98$1,609
Carvedilol184$1,583
Amlodipine Besylate175$1,263
Ezetimibe45$1,162
Clonidine14$1,071

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$42$133,694128 claims
Johnson & JohnsonXarelto$163$25,27521 claims
NovartisEntresto$62$12,35616 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 653 gerontology providers in Texas.

Other gerontology in Galveston

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →